0G8X

Immunovia Ab (publ) (0G8X)

Immunovia Ab (publ)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:0G8X

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/20	00:06	PR Newswire (US)	End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding	LSE:0G8X	Immunovia Ab (publ)
2024/01/05	00:59	PR Newswire (US)	Immunovia announces financial calendar for financial year 2024	LSE:0G8X	Immunovia Ab (publ)
2024/01/05	00:58	PR Newswire (US)	Immunovia announces financial calendar for financial year 2024	LSE:0G8X	Immunovia Ab (publ)
2023/11/21	19:40	PR Newswire (US)	Bulletin from the extraordinary general meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
2023/11/21	19:38	PR Newswire (US)	Bulletin from the extraordinary general meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
2023/11/09	17:03	PR Newswire (US)	Immunovia Publishes Interim Report for January-September 2023	LSE:0G8X	Immunovia Ab (publ)
2023/11/09	16:59	PR Newswire (US)	Immunovia Publishes Interim Report for January-September 2023	LSE:0G8X	Immunovia Ab (publ)
2023/11/08	00:14	PR Newswire (US)	Immunovia successfully completes discovery phase of next-generation test development	LSE:0G8X	Immunovia Ab (publ)
2023/11/08	00:12	PR Newswire (US)	Immunovia successfully completes discovery phase of next-generation test development	LSE:0G8X	Immunovia Ab (publ)
2023/11/02	19:02	PR Newswire (US)	Invitation to Immunovia's Q3 presentation	LSE:0G8X	Immunovia Ab (publ)
2023/11/02	19:00	PR Newswire (US)	Invitation to Immunovia's Q3 presentation	LSE:0G8X	Immunovia Ab (publ)
2023/10/27	16:06	PR Newswire (US)	CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)	LSE:0G8X	Immunovia Ab (publ)
2023/10/27	16:03	PR Newswire (US)	CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)	LSE:0G8X	Immunovia Ab (publ)
2023/10/03	18:01	PR Newswire (US)	Nomination Committee appointed for Immunovia AB (Publ)	LSE:0G8X	Immunovia Ab (publ)
2023/10/03	17:56	PR Newswire (US)	Nomination Committee appointed for Immunovia AB (Publ)	LSE:0G8X	Immunovia Ab (publ)
2023/08/30	19:30	PR Newswire (US)	Immunovia Publishes Interim Report for January-June 2023	LSE:0G8X	Immunovia Ab (publ)
2023/08/30	15:56	PR Newswire (US)	Immunovia Publishes Interim Report for January-June 2023	LSE:0G8X	Immunovia Ab (publ)
2023/08/24	03:08	PR Newswire (US)	Invitation to Immunovia's Q2 presentation	LSE:0G8X	Immunovia Ab (publ)
2023/08/24	03:06	PR Newswire (US)	Invitation to Immunovia's Q2 presentation	LSE:0G8X	Immunovia Ab (publ)
2023/07/20	01:47	PR Newswire (US)	Immunovia announces updated financial calendar	LSE:0G8X	Immunovia Ab (publ)
2023/07/12	16:15	PR Newswire (US)	Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection	LSE:0G8X	Immunovia Ab (publ)
2023/07/12	16:12	PR Newswire (US)	Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection	LSE:0G8X	Immunovia Ab (publ)
2023/06/09	17:19	PR Newswire (US)	Chief Executive Officer, Jeff Borcherding, buys Immunovia shares	LSE:0G8X	Immunovia Ab (publ)
2023/06/09	17:11	PR Newswire (US)	Chief Executive Officer, Jeff Borcherding, buys Immunovia shares	LSE:0G8X	Immunovia Ab (publ)
2023/05/31	19:16	PR Newswire (US)	Change in number of shares and votes in Immunovia AB (publ)	LSE:0G8X	Immunovia Ab (publ)
2023/05/31	19:13	PR Newswire (US)	Change in number of shares and votes in Immunovia AB (publ)	LSE:0G8X	Immunovia Ab (publ)
2023/05/26	20:43	PR Newswire (US)	Bulletin from the Annual General Meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
2023/05/26	20:41	PR Newswire (US)	Bulletin from the Annual General Meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
2023/05/23	16:03	PR Newswire (US)	Immunovia Publishes Interim Report for January-March 2023	LSE:0G8X	Immunovia Ab (publ)
2023/05/23	16:00	PR Newswire (US)	Immunovia Publishes Interim Report for January-March 2023	LSE:0G8X	Immunovia Ab (publ)